Madrid, Spain

Jesus Jeronimo Pintor


 

Average Co-Inventor Count = 4.8

ph-index = 1

Forward Citations = 23(Granted Patents)


Company Filing History:


Years Active: 2004-2015

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Jesus Jeronimo Pintor

Introduction

Jesus Jeronimo Pintor is a notable inventor based in Madrid, Spain. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of ocular conditions. With a total of two patents to his name, Pintor's work focuses on innovative compounds and methods for reducing intraocular pressure.

Latest Patents

Pintor's latest patents include "Uridine di- or tri-phosphate derivatives and uses thereof." This patent discloses specific uridine compounds that are useful for treating diseases modulated by P2Y receptors, particularly for lowering intraocular pressure and treating conditions such as glaucoma. Another significant patent is the "Method for reducing intraocular pressure using indole derivatives." This invention provides a method for lowering intraocular pressure through the administration of pharmaceutical compositions that include indole derivatives and melatonin analogs. A preferred embodiment of this method utilizes 5-(methoxycarbonylamino)-N-acetyltryptamine, known for its prolonged action and efficacy in treating ocular hypertension.

Career Highlights

Throughout his career, Pintor has worked with various institutions, including Bar-Ilan University. His research has focused on developing innovative solutions for ocular health, contributing to advancements in the pharmaceutical industry.

Collaborations

Pintor has collaborated with notable individuals such as Maria A Peral and Ward M Peterson. These collaborations have further enriched his research and development efforts in the field of ocular treatments.

Conclusion

Jesus Jeronimo Pintor is a distinguished inventor whose work has significantly impacted the treatment of ocular hypertension and glaucoma. His innovative patents reflect his commitment to advancing pharmaceutical solutions for eye health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…